scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1056/NEJM198805053181806 |
P698 | PubMed publication ID | 3283549 |
P2093 | author name string | Gawin FH | |
Ellinwood EH Jr | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1173-1182 | |
P577 | publication date | 1988-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Cocaine and other stimulants. Actions, abuse, and treatment | |
P478 | volume | 318 |
Q44193367 | 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization |
Q37185327 | A Longitudinal Examination of Physiological Regulation in Cocaine-Exposed Infants Across the First 7 Months of Life |
Q89472210 | A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder |
Q41534472 | A neuroendocrine role in cocaine reinforcement |
Q39472659 | A primer on neurotransmitters and cocaine |
Q30450348 | Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence |
Q31580357 | Activation of an effector immediate-early gene arc by methamphetamine |
Q43652669 | Acute aortic dissection after cocaine and sildenafil abuse |
Q41736731 | Acute neurologic complications of drug and alcohol abuse |
Q35098069 | Advantages of Joint Modeling of Component HIV Risk Behaviors and Non-Response: Application to Randomized Trials in Cocaine-Dependent and Methamphetamine-Dependent Populations. |
Q38634035 | Adverse health consequences of cocaine abuse |
Q43949675 | Age differences in HIV risk behaviors and drug treatment utilization among drug users in Kentucky |
Q34764565 | Alcohol protracted withdrawal syndrome: the role of anhedonia. |
Q51988728 | Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. |
Q44525657 | Alcoholism in 274 patients with panic disorder in Spain, one of the main producers of wine worldwide |
Q34576700 | Alloimmunization and intravenous drug abuse |
Q38687912 | Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurones induced by chronic psychostimulant administration and stress: relevance to behavioural sensitization and drug addiction. |
Q51420636 | Altered sensitivity of dopamine autoreceptors in rat accumbens 1 and 7 days after intermittent or continuous cocaine withdrawal. |
Q36930257 | Among long-term crack smokers, who avoids and who succumbs to cocaine addiction? |
Q58089456 | Amphetamine Misuse: The Effects Of Social Context On Injection Related Risk Behaviour |
Q33591050 | Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure |
Q48766968 | Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment |
Q48757334 | An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics |
Q42595096 | An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors |
Q42728896 | Anhedonia and substance dependence: clinical correlates and treatment options. |
Q36481299 | Animal models of drug addiction: Where do we go from here? |
Q41550884 | Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction |
Q40733293 | Assessment of the management outcomes of body packers |
Q34187861 | Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users |
Q51481167 | Auricular acupuncture in the treatment of cocaine abuse. A study of efficacy and dosing. |
Q45974506 | Barriers and pathways to diffusion of methamphetamine use among African Americans in the rural South: preliminary ethnographic findings. |
Q30586916 | Behavior problems among cocaine exposed children: role of physiological regulation and parenting |
Q42489385 | Behavioral and neurochemical sensitization following cocaine self-administration |
Q40385865 | Behavioral development in children prenatally exposed to drugs and alcohol |
Q42603940 | Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion |
Q43991237 | Behavioral sensitization is greater after repeated versus single chronic cocaine dosing regimens. |
Q36938316 | Biological treatments for amfetamine dependence : recent progress |
Q51768737 | Breaking the Cycle of Addiction |
Q72013042 | Bursting firing of action potentials in central snail neurons elicited by d-amphetamine: role of the electrogenic sodium pump |
Q51755594 | Carbamazepine for cocaine addiction? |
Q24241962 | Carbamazepine for cocaine dependence |
Q43868894 | Carbamazepine toxicity after influenza vaccination |
Q34352383 | Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine |
Q34274613 | Cerebral blood flow and metabolism in anxiety and anxiety disorders |
Q34863066 | Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk |
Q36545079 | Clinical effects and management of methamphetamine abuse |
Q46017052 | Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation. |
Q35053244 | Co-Occurring Depressive and Substance Use Disorders in Adolescents: An Examination of Reward Responsiveness During Treatment |
Q35046679 | Cocaine Exposure and Children's Self-Regulation: Indirect Association via Maternal Harshness |
Q41088457 | Cocaine addiction: relationship to seasonal affective disorder |
Q48312348 | Cocaine adversely affects development of cortical embryonic neurons in vitro: immunocytochemical study of calcium-binding proteins |
Q44333352 | Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum |
Q33904593 | Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives |
Q34034497 | Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels |
Q44830707 | Cocaine disrupts both behavioural inhibition and conditional discrimination in rats |
Q36870205 | Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users. |
Q35525488 | Cocaine exposure in utero: perinatal development and neonatal manifestations--review |
Q38701279 | Cocaine intoxication |
Q81884313 | Cocaine intoxication |
Q35558194 | Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs |
Q48891589 | Cocaine use and withdrawal: the effect on sleep and mood |
Q40944631 | Cocaine using during pregnancy and low birth weight: the impact of prenatal care and drug treatment |
Q45086422 | Cocaine-induced rausch: overt behaviour and plasma concentrations in rhesus monkeys |
Q37040384 | Cocaine: The Newest Risk Factor for Cardiovascular Disease |
Q46207950 | Cocaine: an independent risk factor for aortic sudanophilia. A preliminary report |
Q38713576 | Cocaine: clinical pharmacology and toxicology |
Q42541045 | Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice |
Q41527898 | Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies |
Q51577950 | Cognitive effects of cocaine and polydrug abuse. |
Q28379524 | Cognitive functioning in 8- to 18-month-old drug-exposed infants |
Q52058370 | Cognitive impairments in adolescent drug-abusers. |
Q43860906 | Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence |
Q44668785 | Complications of cocaine use. |
Q51590650 | Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. |
Q51146671 | Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. |
Q39384646 | Correlates of cocaine/crack use among inner-city incarcerated adolescents |
Q37426195 | Corticosterone levels determine individual vulnerability to amphetamine self-administration |
Q28477569 | Cues paired with either rapid or slower self-administered cocaine injections acquire similar conditioned rewarding properties |
Q44778333 | Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio |
Q36494775 | Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence |
Q43826444 | Density functional theory investigation of cocaine water complexes |
Q39406768 | Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample |
Q45974794 | Diazepam in the prevention of seizures and death in cocaine-intoxicated rats. |
Q28200205 | Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum |
Q46772970 | Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges |
Q43700718 | Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors |
Q51762421 | Double-blind evaluation of the effect of acute amantadine on cocaine craving. |
Q40645990 | Drug-induced hyperthermia |
Q33933033 | Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin. |
Q37035332 | Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence |
Q45176485 | Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality |
Q51699083 | Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats |
Q34205130 | Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding. In vivo and in vitro analysis |
Q34183716 | Effects of cocaine on excitation-contraction coupling of aortic smooth muscle from the ferret |
Q34839561 | Effects of prenatal cocaine exposure on infant reactivity and regulation |
Q32144325 | Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation |
Q46922241 | Emergency department utilization by crack-cocaine smokers in Dayton, Ohio |
Q36731050 | Emergency management of cocaine intoxication. Counteracting the effects of today's 'favorite drug'. |
Q38271498 | Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy |
Q40789555 | Entangled epidemics: cocaine use and HIV disease |
Q35427073 | Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. |
Q52603075 | Evaluation of the combined toxic effects of cocaine and ethanol on primary myocardial cell cultures |
Q55010835 | Evaluation of the effect of methamphetamine on traumatic injury complications and outcomes. |
Q30357532 | Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence. |
Q44497285 | Facilitation of ejaculation after methamphetamine administration in paradoxical sleep deprived rats |
Q40197141 | Factors associated with the initiation of cocaine and heroin among problem drug users: reflections on interventions |
Q36748790 | Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. |
Q30479705 | Fetal effects of psychoactive drugs |
Q33873855 | First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine |
Q72437817 | Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use |
Q33758894 | How to spot illicit drug abuse in your patients |
Q43861563 | Human therapeutic cocaine vaccine: safety and immunogenicity |
Q34239759 | Hyperthermia in sauna is unable to increase the plasma levels of ACTH/cortisol, beta-endorphin and prolactin in cocaine addicts |
Q51146682 | Improved performance 4 hours after cocaine. |
Q39472665 | Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine |
Q41665903 | In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats |
Q36542369 | Inhibition in the nervous system: models of its roles in choice and context determination |
Q28372687 | Initial validation of the Voris Cocaine Craving Scale: a preliminary report |
Q58547389 | Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence |
Q45266020 | Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan |
Q36832327 | Involvement of reactive oxygen species in cocaine-taking behaviors in rats |
Q51631177 | Is there a cocaine baby syndrome? |
Q36540636 | Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform |
Q28334865 | Lidocaine potentiation of cocaine toxicity |
Q40811281 | Local anesthetics in the management of acute pain in children |
Q48630550 | Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys |
Q44922214 | Measurement of locus of control in cocaine abusers |
Q33645204 | Methamphetamine and the expanding complications of amphetamines |
Q35141831 | Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells |
Q24514758 | Methamphetamine. Stimulant of the 1990s? |
Q40927134 | Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase |
Q40932049 | Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants |
Q33646137 | Multi-System Complications after Intravenous Cocaine Abuse |
Q41926571 | Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. |
Q57793709 | Neural Circuit Motifs in Valence Processing |
Q46430163 | Neural plasticity and addiction: integrin-linked kinase and cocaine behavioral sensitization |
Q36867023 | Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review |
Q30429194 | Neurodevelopmental effects of cocaine |
Q38714755 | Neuroimaging evidence of altered fronto-cortical and striatal function after prolonged cocaine self-administration in the rat. |
Q33616376 | Neurologic aspects of cocaine abuse. |
Q41922304 | Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum |
Q38476968 | Neuropsychological deficits in chronic cocaine abusers |
Q51699201 | Neuropsychological impairment in chronic cocaine abusers |
Q36911344 | Outcomes of cocaine-induced gastric perforations repaired with an omental patch |
Q51715941 | Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. |
Q58268012 | Patterns of Heroin, Cocaine and Speedball Injection Among Bronx (Usa) Methadone Maintenance Patients: 1978-1988 |
Q37184377 | Perceived need for substance abuse treatment among illicit stimulant drug users in rural areas of Ohio, Arkansas, and Kentucky |
Q51623097 | Perioperative care of the cocaine-abusing patient. |
Q40849071 | Persistent cognitive deficits attributed to substance abuse. |
Q43791216 | Personality profile and neuropsychological test performance in chronic cocaine-abusers |
Q51751703 | Personality risk factors for cocaine abuse. |
Q34982551 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine |
Q34448544 | Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users |
Q41890276 | Pharmacologic treatment of cocaine dependence |
Q34256300 | Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy |
Q41739068 | Pharmacotherapy of cerebral ischemia in cocaine dependence |
Q42199751 | Possible cocaine predisposition to adverse cerebrovascular and cardiovascular sequelae of bromocriptine administered postpartum |
Q35872298 | Predictors of depressive symptomatology among rural stimulant users |
Q33921923 | Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience |
Q35111795 | Prenatal Cocaine Exposure and Infant Sleep at 7 Months of age: The Influence of the Caregiving Environment |
Q42277450 | Prenatal cocaine alters later sensitivity to cocaine-induced seizures |
Q34972993 | Prenatal cocaine and other substance exposure: effects on infant autonomic regulation at 7 months of age. |
Q37694913 | Prenatal cocaine exposure and trajectories of externalizing behavior problems in early childhood: examining the role of maternal negative affect |
Q33905400 | Prenatal cocaine exposure: the role of cumulative environmental risk and maternal harshness in the development of child internalizing behavior problems in kindergarten |
Q77462295 | Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment |
Q36426394 | Profiles of Reactivity in Cocaine-Exposed Children. |
Q46503307 | Prognosis of cocaine body-packers |
Q39227357 | Progression of Dependence in Male Cocaine Addicts |
Q51157259 | Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study. |
Q37003250 | Psychosocial and psychopathology differences in hospitalized male and female cocaine abusers: A retrospective chart review |
Q24188253 | Psychosocial interventions for psychostimulant misuse |
Q30245025 | Psychosocial interventions for psychostimulant misuse. |
Q72232854 | Psychostimulants |
Q90033780 | Rate matters: rapid cocaine delivery promotes incubation of cocaine craving |
Q33873862 | Rational design of an enzyme mutant for anti-cocaine therapeutics |
Q50889991 | Recreational drugs. |
Q48265332 | Regional brain metabolic activation during craving elicited by recall of previous drug experiences |
Q48428678 | Regulation of arousal and attention in preschool children exposed to cocaine prenatally |
Q52016666 | Relationship between Concurrent Substance Abuse in Psychiatric Patients and Neuroleptic Dosage |
Q51506131 | Reliability and validity of the Cocaine Selective Severity Assessment. |
Q52625848 | Repeated inhalation of crack-cocaine affects spermatogenesis in young and adult mice. |
Q37971401 | Repetitive transcranial magnetic stimulation and drug addiction. |
Q57787186 | Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association |
Q41047111 | Restlessness: the anatomy of a neuropsychiatric symptom |
Q48489385 | Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. |
Q35040501 | Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine |
Q51766869 | Rhabdomyolysis after intravenous cocaine. |
Q45288306 | Role of withdrawal in reinstatement of morphine-conditioned place preference |
Q34715801 | Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed |
Q51124794 | Serotonergic mechanisms of cocaine effects in humans |
Q48388948 | Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors |
Q32025737 | Serotonin transporters upregulate with chronic cocaine use. |
Q46578862 | Serum Prolactin Level, Craving, and Early Discharge from Treatment in Cocaine-Dependent Patients |
Q51680498 | Severe arteriosclerosis in the kidney of a cocaine addict |
Q48451885 | Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers |
Q37080736 | Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis |
Q42677161 | Sexual behaviour, STDs and drug use in a crack house population |
Q38113985 | Stimulants and the lung : review of literature |
Q33860687 | Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction |
Q36979886 | Subarachnoid haemorrhage associated with MDMA abuse |
Q70746154 | Substance abuse and AIDS: a faculty development program for primary care providers |
Q64980809 | Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence. |
Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
Q40473742 | The Classification of Delusional Disorders |
Q58802903 | The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile during Pregnancy |
Q34466937 | The HPA axis and cocaine reinforcement |
Q73861218 | The applicability of the dependence syndrome to amphetamine |
Q46661186 | The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables. |
Q68201165 | The cardiovascular effects of cocaine |
Q92772619 | The cellular basis of fetal endoplasmic reticulum stress and oxidative stress in drug-induced neurodevelopmental deficits |
Q22305685 | The clinical toxicology of metamfetamine |
Q37280342 | The consequences of maternal substance abuse for the child exposed in utero |
Q45006819 | The drug dilemma: manipulating the demand |
Q36627117 | The effect of cocaine on gastric mucosal PGE(2), LTC(4) and ulcerations |
Q28370861 | The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function |
Q46357879 | The effects of gestational cocaine exposure on pregnancy outcome, postnatal development, cognition and locomotion in rats |
Q46559852 | The evaluation of the JEWEL project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution |
Q69521192 | The management of pain in sickle cell disease |
Q28361466 | The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs |
Q34581491 | The potential of dopamine agonists in drug addiction |
Q44209893 | The prevalence and correlates of depressive symptomatology among a community sample of crack-cocaine smokers |
Q68735335 | The prevalence of high-risk sexual behavior in male intravenous drug users with steady female partners |
Q40815121 | The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. |
Q47777077 | The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake |
Q41169149 | The substance-using human immunodeficiency virus patient: approaches to outpatient management. |
Q48515555 | The thymolytic effect of cocaine and monoaminergic drugs in the mouse |
Q35454891 | Therapeutic options and challenges for substances of abuse. |
Q35193474 | Therapeutic vaccines for substance dependence |
Q35781905 | Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats |
Q48716497 | Tolerance and sensitization to the behavioral effects of cocaine in rats: relationship to benzodiazepine receptors |
Q44474511 | Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale |
Q40468191 | Toxicity and Abuse of Prescribed Stimulants |
Q45971403 | Transient Cortical Blindness in an Infant Exposed to Methamphetamine |
Q47571629 | Treatment of crack cocaine use with carbamazepine |
Q34233794 | Treatments for methamphetamine abuse: a literature review for the clinician |
Q42077507 | Unexpected cocaine intoxication presenting as seizures in children |
Q42580721 | Update on amphetamine abuse. |
Q36383595 | Use of methylphenidate in patients with cancer |
Q41151363 | Use of stimulants in the medically ill. |
Q35670493 | Use of tetracaine, epinephrine, and cocaine as a topical anesthetic in the emergency department |
Q35111444 | Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress |
Q52279167 | [Psychopathologic evaluation of cocaine-dependent patients]. |
Search more.